Latest Research

It can be overwhelming to stay on top of all the ongoing research in the area of Alzheimer's disease and other types of dementia.

Learning Specialist, Padmaja Genesh, removes the guesswork and provides a monthly update on all of the noteworthy information regarding dementia. Below you'll find some highlights from recent months.

All of the updates are available to download on the right side of the screen.

Latest Hightlights from March 2020

  • Cognitive Difficulties Can Predict Neurodegeneration, Study Finds
  • DNA from Bacteria in Brain May Promote Tau Clumping, Study Suggests
  • Evidence on Cognitive Impairment Screening in Older Adults Is Insufficient, Panel Says
  • Neurosteer Promotes Wearable Monitor to Detect Early Alzheimer’s
  • PSEN1 Gene Alteration May Be Early Biomarker for Alzheimer’s, Study Suggests
  • Stress-Related Disorders Are Associated with Increased Risk of Neurodegenerative Disease
  • Blood Test Can Differentiate Alzheimer’s From Other Dementias, Research Suggests
  • How and Why Living in Disadvantaged Communities Contributes to Neurodegeneration

Latest Highlights from February 2020

  • Memory Health Awarded UK Patent as Alzheimer’s Treatment
  • Inflammatory Conditions Linked to Higher Risk of Alzheimer’s
  • Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals?
  • FDA to Review Adlarity as Skin Patch Treatment for Alzheimer’s Dementia
  • Dietary flavonols and risk of Alzheimer dementia
  • Antipsychotics Are Associated with an Increased Risk for Traumatic Brain Injury in People with Alzheimer’s Disease
  • Evidence on Cognitive Impairment Screening in Older Adults Is Insufficient, Panel Says
  • Solanezumab and Gantenerumab Fail to Slow Memory Loss or Cognitive Decline in Early-onset Alzheimer’s, Study Finds
  • Biogen to Start Re-dosing Aducanumab in Alzheimer’s Patients From Halted Trials
  • New Carbon Nanotube Sensor Ably Spots Alzheimer’s via Proteins in Blood, Study Reports

Latest Highlights from January 2020

  • Anti-Amyloid antibodies clear brain amyloid, would they improve cognition?
  • Exercise and Brain Health Activities Are Associated with a Slower Rate of Frontotemporal Dementia (FTD)
  • The Role that Fragmented Sleep Plays in Cognition
  • Vascular Dysfunction Taxes Cognition, but Not Via Amyloid, AD

Latest Highlights from October & November 2019

  • Seaweed-based Therapy Approved in China for Mild to Moderate Alzheimer’s, 1st New Treatment in 16 Years
  • Biogen to Seek Approval of Aducanumab for Early Alzheimer’s based on New Analysis of Trials
  • Nuplazid Significantly Delays Relapses in Dementia-related Psychosis, Phase 3 Study Shows
  • Longitudinal Blood Pressure Changes, Starting at Midlife, May Indicate Need for Earlier Treatment of Cognitive Decline
  • ApoE4 and Tau in Alzheimer’s: Worse than We Thought? Especially in Women
  • Childhood Cognitive Ability May Predict Cognition at Age 70
  • Income Fluctuations in Early Adulthood May Impair Brain Aging in Midlife, Study Finds

Latest Highlights from September 2019

  • Alzheimer’s Vaccine Found Safe, Effective in Patients with Mild Forms of the Disease, Phase 2 Study Finds
  • Phase 3 Trial Suggests Pimavanserin Assuages Psychosis in Dementia
  • Bryostatin-1 Fails to Ease Dementia in Moderate-to-Severe Alzheimer’s Patients in Phase 2 Trial
  • End of the BACE Inhibitors? Elenbecestat Trials Halted Amid Safety Concerns
  • ADvance II Study Testing Deep Brain Stimulation in Mild Alzheimer’s Started, Enrollment Ongoing
  • Diet Directly Affects Gut Bacteria and May Contribute to Alzheimer’s Progression, Pilot Study Suggests

 

Visit our video library to learn more and see Padmaja discuss several hot topics.

Padmaja Genesh
Learning Specialist, Alzheimer Society of Calgary

Padmaja Genesh is the Learning Specialist for the Alzheimer Society of Calgary. On top of her research, Padmaja is an educator. Throughout the year, she facilitates professional training sessions and also delivers educational presentations throughout the community.